Showing results (271-280 of 311) with videos related to

Sort By:
Pageof 32
Plos One|February 6, 2014
Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumorsMichael L Megison, Lauren A Gillory, Jerry E Stewart, et al.
Neurosurgery|July 14, 2023
Understanding the Effect of Prescription Isodose in Single-Fraction Stereotactic Radiosurgery on Plan Quality and Clinical Outcomes for Solid Brain MetastasesMatthew H Brown, Samuel R Marcrom, Mayank P Patel, et al.
Theranostics|March 17, 2025
Comparison of 5-aminolevulinic acid and MMP-14 targeted peptide probes in preclinical models of GBMBenjamin B Kasten, Tingting Dai, Ke Jiang, et al.
Advances in Radiation Oncology|March 2, 2026
Comparison of 3 vs 5 Fraction Single Isocenter Radiosurgery for Brain MetastasesLuke A Moradi, Richard A Popple, Roman L Travis, et al.
Theranostics|January 9, 2026
Quantitative dynamic granzyme B PET imaging to characterize novel combination immunotherapy response in preclinical glioblastoma modelsCarlos A Gallegos, Yun Lu, Patrick N Song, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 27, 2019
Repeat gamma knife stereotactic radiosurgery in the treatment of trigeminal neuralgia: A single-center experience and focused review of the literatureN B Omar, J W Amburgy, D M Self, et al.
Scientific Reports|September 19, 2018
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 ExpressionGregory K Friedman, Joshua D Bernstock, Dongquan Chen, et al.
Human Gene Therapy|July 14, 2020
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain TumorsJoshua D Bernstock, Asim K Bag, John Fiveash, et al.
Annals of the Royal College of Surgeons of England|November 14, 2018
Is it always necessary to perform an axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer?I Osorio-Silla, A Gómez Valdazo, J I Sánchez Méndez, et al.
The Journal of Biological Chemistry|May 18, 2006
Surface expression of ASIC2 inhibits the amiloride-sensitive current and migration of glioma cellsWanda H Vila-Carriles, Gergely Gy Kovacs, Biljana Jovov, et al.
Pageof 32